The Recall Desk
HighFDA (Devices)·Z-1317-2019·Announced 2019-05-22

Philips SureSigns VS3 NBP Recall for Pulse Rate Measurement Limitation

Philips is recalling SureSigns VS3 NBP monitors because software prevents the display and alarm for pulse rates above 240 beats per minute.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk-of-harm product (medical monitor) where the failure to alarm for high pulse rates poses a safety risk, though no specific injuries are reported in the source text.

Plain-English summary

Philips North America, LLC is recalling 1,397 units of the SureSigns VS3 NBP monitor (Product Number 863069). These devices are used to monitor physiological parameters, including non-invasive blood pressure, oxygen saturation, and temperature.

The recall is due to a system software defect that inhibits the monitor's ability to measure, display, and alarm for pulse rates above 240 beats per minute. This limitation may prevent healthcare providers from receiving critical alerts for patients with extremely high heart rates.

The affected devices were distributed worldwide, including in the United States, Puerto Rico, and numerous international locations. Healthcare facilities and users should contact Philips for further instructions on how to address this software issue.

The recalled product

Product
SureSigns VS3 NBP, Product Number 863069. For monitoring the physiological parameters of patients (NBP, SpO2 & Temperature).
Affected units
1,397

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 8 recalled by Philips North America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 8 products in this recall →